DOT1L inhibitors (Chinese Academy of Sciences/Peking/ShanghaiTech/University Of Science & Technology Of China)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDOT1L inhibitors (Chinese Academy of Sciences/Peking/ShanghaiTech/University Of Science & Technology Of China)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDOT1 like histone lysine methyltransferase inhibitors
TargetsDOT1 like histone lysine methyltransferase
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinese Academy Of SciencesPeking UniversityShanghaiTech University +[4] 
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A